ENDRA Life Sciences Depreciation & Amortization 2011-2026 | NDRA

Annual Depreciation & Amortization ENDRA Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
44 K	46.5 K	124 K	96.7 K	116 K	99.3 K	80.6 K	68.3 K	61.5 K	64.9 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
124 K	44 K	80.2 K

Quarterly Depreciation & Amortization ENDRA Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.8 K	-	13.8 K	-	11.5 K	-	15.3 K	-	32.1 K	35.3 K	34.5 K	-	64.5 K	21.7 K	19 K	-	95 K	65.2 K	31.4 K	-	45.1 K	44 K	21.6 K	-	59.7 K	39.7 K	19.6 K	-	48.2 K	30.2 K	15.3 K	-	46.1 K	31 K	15.7 K	-	48.6 K	32.3 K	16.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
95 K	10.8 K	34.4 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Burning Rock Biotech Limited BNR	47.8 M	$ 18.56	10.74 %	$ 196 M	China
Agilent Technologies A	321 M	-	-	$ 34.4 B	USA
Castle Biosciences CSTL	40.8 M	$ 18.88	4.02 %	$ 547 M	USA
Fulgent Genetics FLGT	24.9 M	$ 16.19	1.44 %	$ 490 M	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Interpace Biosciences IDXG	425 K	$ 1.8	-5.26 %	$ 7.96 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	15 M	$ 20.49	-0.58 %	$ 1.09 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Medpace Holdings MEDP	27.2 M	$ 419.17	-1.08 %	$ 12.1 B	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Lantheus Holdings LNTH	70.1 M	-	-	$ 6.5 B	USA
Mettler-Toledo International MTD	51.1 M	$ 1 041.91	1.75 %	$ 21.5 B	Schweiz
Myriad Genetics MYGN	53.7 M	$ 3.62	-2.95 %	$ 335 M	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Co-Diagnostics CODX	1.11 M	$ 1.63	1.87 %	$ 2.17 M	USA
NeoGenomics NEO	36.1 M	$ 8.36	1.21 %	$ 1.07 B	USA
National Research Corporation NRC	7.62 M	$ 18.93	1.39 %	$ 424 M	USA
Natera NTRA	16.7 M	$ 196.91	0.81 %	$ 19.4 B	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	403 M	$ 159.12	-2.29 %	$ 7.89 B	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 25.5	-0.51 %	$ 24.2 B	Niderland
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Personalis PSNL	10 M	$ 6.71	5.01 %	$ 599 M	USA
Guardant Health GH	39.7 M	$ 98.66	0.19 %	$ 12.4 B	USA
Senseonics Holdings SENS	1.51 M	$ 5.82	5.82 %	$ 243 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	488 M	$ 117.09	-0.25 %	$ 9.66 B	Irlanda
Illumina ILMN	354 M	$ 143.24	-1.21 %	$ 22.8 B	USA
Soleno Therapeutics SLNO	2.02 M	$ 52.99	0.08 %	$ 2.69 B	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Twist Bioscience Corporation TWST	24.9 M	$ 52.95	-2.65 %	$ 3.17 B	USA
Biomerica BMRA	87 K	$ 2.41	7.11 %	$ 5.54 M	USA
Thermo Fisher Scientific TMO	1.05 B	$ 448.21	0.49 %	$ 169 B	USA
Laboratory Corporation of America Holdings LH	681 M	$ 254.02	-0.16 %	$ 21.1 B	USA
Waters Corporation WAT	88.1 M	$ 333.21	-0.51 %	$ 19.8 B	USA
Celcuity CELC	167 K	$ 134.72	8.23 %	$ 6.3 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	119 M	$ 8.43	-2.99 %	$ 1.83 B	USA